AI-Designed Dog Cancer Vaccine Startup Gamgee Raises $4M Seed
机器之心 · wechat · 2026-08-23
Paul Conyngham, a tech entrepreneur with no medical background, used AI tools like ChatGPT and AlphaFold to design a personalized mRNA vaccine for his dog Rosie, which initially reduced her tumors. Although Rosie eventually passed away, this effort led to the founding of Gamgee.
Gamgee has raised $4 million in seed funding led by Founders Fund. The company aims to industrialize this personalized workflow, sequencing tumors and using AI to identify neoantigens for custom "N-of-1" vaccines for dogs. Clinical trials are launching in Australia. The story highlights that while AI accelerates target identification, the bottleneck for personalized cancer vaccines remains the overall timeline of approval and production.
Related event: Founder Who Used AI to Design Cancer Vaccine for His Dog Raises $4M(2 posts)→
More from Venture
- Audit of top 100 Outbid sites: only 11 retained UTM attribution data — HaktanSuren · 2026-08-23
- Testimonial Tops the Creative Billboard Billbored — ayushtweetshere · 2026-08-23
- Indie hackers passing the same money around among outbid clones — iannuttall · 2026-08-23
- Confetti Therapy launches bidding-style Million Dollar Challenge leaderboard — ThePeterMick · 2026-08-23
- Six Grok Bot Agents Replace a $294K Wall Street Research Desk for $200/Month — minchoi · 2026-08-23
- Master prompt builds a full pay-to-rank app: schema, Stripe, RLS included — aliscodes · 2026-08-23